Skip to main content
Midas Edge

LEMAITRE VASCULAR INC

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

LMAT$80.89-3.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

LEMAITRE VASCULAR

FORM 10-Q

TABLE OF CONTENTS

Page
Part I.Financial Information:4
Item 1.Financial Statements4
Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 20244
Unaudited Consolidated Statements of Operations for the three-month periods ended March 31, 2025 and 20245
Unaudited Consolidated Statements of Comprehensive Income for the three-month periods ended March 31, 2025 and 20246
Unaudited Consolidated Statements of Stockholders’ Equity for the three-month periods ended March 31, 2025 and 20247
Unaudited Consolidated Statements of Cash Flows for the three-month periods ended March 31, 2025 and 20248
Notes to Unaudited Consolidated Financial Statements9
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations20
Item 3.Quantitative and Qualitative Disclosure about Market Risk28
Item 4.Controls and Procedures28
Part II.Other Information:30
Item 1.Legal Proceedings30
Item 1A.Risk Factors30
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds30
Item 5.Other Information31
Item 6.Exhibits32
Signatures33

Part I. Financial Information

LeMaitre Vascular, Inc.

Consolidated Balance Sheets

(unaudited)
March 31,December 31,
20252024
(in thousands, except share data)
Assets
Current assets:
Cash and cash equivalents$25,340$25,610
Short-term marketable securities277,209274,112
Accounts receivable, net of allowances of $1,429 at March 31, 2025 and $1,369 at December 31, 202435,11230,063
Inventory and other deferred costs65,90664,927
Prepaid expenses and other current assets4,5467,480
Total current assets408,113402,192
Property and equipment, net25,10624,800
Right-of-use leased assets16,23316,768
Goodwill65,94565,945
Other intangibles, net34,39935,819
Deferred tax assets1,0371,425
Other assets5,1734,868
Total assets$556,006$551,817
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$2,181$1,761
Accrued expenses19,92924,732
Acquisition-related obligations-1,433
Lease liabilities - short-term2,6352,681
Total current liabilities24,74530,607
Convertible senior notes, net167,984167,772
Lease liabilities - long-term14,74215,232
Deferred tax liabilities8885
Other long-term liabilities875831
Total liabilities208,434214,527
Stockholders’ equity:
Preferred stock, $0.01 par value; authorized 3,000,000 shares; none outstanding--
Common stock, $0.01 par value; authorized 37,000,000 shares; issued 24,204,191 shares at March 31, 2025, and 24,153,165 shares at December 31, 2024242242
Additional paid-in capital217,118213,760
Retained earnings151,584145,090
Accumulated other comprehensive loss(5,153)(6,184)
Treasury stock, at cost; 1,609,890 shares at March 31, 2025 and 1,603,825 shares at December 31, 2024(16,219)(15,618)
Total stockholders’ equity347,572337,290
Total liabilities and stockholders’ equity$556,006$551,817
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.